MOMA Hereditary Cancer Panel (targeted NGS) v5 - 124 genes, 2022-08-18

ABRAXAS1, ACD, AIP, AKT1, AP2S1, APC, ATM, ATR, AXIN2, BAP1, BARD1, BLM, BMPR1A, BRCA1, BRCA2, BRIP1, BUB1, BUB3, CASR, CDC73, CDH1, CDK4, CDKN1A, CDKN1B, CDKN2A, CDKN2B, CDKN2C, CHEK1, CHEK2, CTNNA1, CTNNB1, DICER1, ENG, EPAS1, EPCAM, EXO1, FAN1, FANCC, FANCM, FH, FLCN, GALNT12, GEN1, GNA11, GNAS, HOXB13, KIT, LZTR1, MAP3K6, MAX, MDH2, MEN1, MET, MITF, MLH1, MLH3, MRE11, MSH2, MSH3, MSH6, MUTYH, NBN, NF1, NF2, NTHL1, NTRK1, OGG1, PALB2, PDGFRA, PIK3CA, PMS1, PMS2, POLD1, POLE, POLE2, POT1, PPM1D, PRKAR1A, PRSS1, PTCH1, PTCH2, PTEN, RAD50, RAD51, RAD51B, RAD51C, RAD51D, RB1, RBBP8, RET, RINT1, RNF43, RPS20, SCG5 (GREM1 enhancer), SDHA, SDHAF2, SDHB, SDHC, SDHD, SEC23B, SEMA4A, SLC25A11, SLX4, SMAD4, SMARCA4, SMARCB1, SMARCE1, SMO, SPINK1, SPRED1, STK11, SUFU, TERF2IP, TERT, TMEM127, TP53, TP53BP1, TSC1, TSC2, UIMC1, VHL, WWP1, XRCC2, XRCC3